Multidisciplinary management of head and neck cancers is essential to both understanding current treatment paradigms and tailoring treatment to the individual patient.  Part of optimizing care is to understand how to intensify treatment in unfavorable cases while deescalating therapy in low risk

This course reviews the current state of treatment paradigms for the most common pediatric solid tumors requiring radiotherapy. The pitfalls and how to avoid them during treatment planning and best practices will be discussed.

This panel session brings together four experts who can present recent advances in gynecological oncology research and how it can guide our current practice.

In this practical, case based educational session we will review fundamental elements of spine SBRT by reviewing 3 specific case scenarios: 

This workshop was developed in collaboration between ASTRO and Society for Immunotherapy of Cancer (SITC). The workshop provides examples of different settings and study design to test currently available commercial immunotherapies combined with radiation therapy.

This panel focused on the guideline recommendations and videntiary base for radiation treatment of basal and squamous cell cancers of the skin.

In this session, presenters will discuss the controversies involved in radiotherapy decision-making in the era of neoadjuvant systemic therapy. Data from randomized trials will be described where available, along with the relevant strengths and limitations.

Forty percent of radiation therapy in the United States is given with palliative intent. At the same time, palliative RT receives disproportionately low attention at national meetings, is not well studied on clinical protocols. Palliative RT remains more of an art than clinical science.

Highlights from the best scientific abstracts in thoracic radiotherapy from ASTRO 2019 will be reviewed and placed in perspective with current literature, practice guidelines and patterns of care.  Attendees should leave with a better understanding of how to incorporate these data into daily prac

There has been a recent flurry of practice-changing options for managing brain and spine metastases as a result of refinements in pathological classification of tumors, better systemic management options, improved imaging permitting precise localization of pathology and avoidance structures withi